Mandate

Vinge advises Arthur J. Gallagher

July 08, 2016

Vinge advises Arthur J. Gallagher in connection with its acquisition of 85% of Brim AB (Brim). Brim’s annualized revenues total approximately $11 million.
 
Founded in 2001, Brim is a specialty insurance and reinsurance broker that provides commercial property/casualty, credit/political risk and affinity insurance products and services to its Scandinavian and international clients. Its credit and political risk practice provides financing support for major infrastructure projects while its construction practice supports residential and commercial building development.
 
Vinge with lead partner Johan Göthberg advised AJG with a team consisting of Oscar Rydén as senior associate (M&A), Axel Hedberg (insurance and regulatory), Sara Strandberg (employment) and Emilie Parland (tax).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025